Lv63
2680 积分 2022-07-07 加入
Circulating tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors: a Systematic Review and Meta-Analysis
2天前
已完结
Korea, Japan, Europe, and the United States: Why are guidelines for gastric cancer different?
18天前
已完结
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study
20天前
已完结
Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 Non-Small Cell Lung Cancer: Primary Results from SQUAT trial (WJOG 12119L)
29天前
已完结
HER2 testing: evolution and update for a companion diagnostic assay
1个月前
已完结
De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?
1个月前
已完结
Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs
1个月前
已完结
The Drug-Dosing Conundrum in Oncology — When Less Is More
1个月前
已完结
MYC in cancer: from undruggable target to clinical trials
1个月前
已完结
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
1个月前
已完结
皖公网安备34019202002308
